|
|
|
|
|
by mtgx
3107 days ago
|
|
The article explains why it's so expensive: > Why are prices so different in the U.S.? > "In other countries, there are price control methods. The government steps in to ensure drug prices do not increase by a certain amount," Alpern says. "There are no price control mechanisms in the U.S." > Between 2011 and 2016, mebendazole's price jumped more than 8,000 percent, from $4.50 to $369. So it was indeed $4.5 in the U.S. - until the company decided to get greedy. |
|
In other words, the article explains why the price growth was not capped. It does not explain why it grew in the first place.
In general I wish the drug company had taken time to contribute to this article and show their side of the story.